Chatterjee S, Browning EA, Hong N, DeBolt K, Sorokina EM, Liu W, Birnbaum MJ, Fisher AB. Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS. Am J Physiol Heart Circ Physiol 302: H105-H114, 2012. First published October 14, 2011 doi:10.1152/ajpheart.00298.2011.-Loss of fluid shear stress (ischemia) to the lung endothelium causes endothelial plasma membrane depolarization via ATP-sensitive K ϩ (KATP) channel closure, initiating a signaling cascade that leads to NADPH oxidase (NOX2) activation and ROS production. Since wortmannin treatment significantly reduces ROS production with ischemia, we investigated the role of phosphoinositide 3-kinase (PI3K) in shearassociated signaling. Pulmonary microvascular endothelial cells in perfused lungs subjected to abrupt stop of flow showed membrane depolarization and ROS generation. Stop of flow in flow-adapted mouse pulmonary microvascular endothelial cells in vitro resulted in the activation of PI3K and Akt as well as ROS generation. ROS generation in the lungs in situ was almost abolished by the PI3K inhibitor wortmannin and the PKC inhibitor H7. The combination of the two (wortmannin and H7) did not have a greater effect. Activation of NOX2 was greatly diminished by wortmannin, knockout of Akt1, or dominant negative PI3K, whereas membrane depolarization was unaffected. Ischemia-induced Akt activation (phosphorylation) was not observed with K ATP channel-null cells, which showed minimal changes in membrane potential with ischemia. Activation of Akt was similar to wild-type cells in NOX2-null cells, which do not generate ROS with ischemia. Cromakalim, a K ATP channel agonist, prevented both membrane depolarization and Akt phosphorylation with ischemia. Thus, Akt1 phosphorylation follows cell membrane depolarization and precedes the activation of NOX2. These results indicate that PI3K/Akt and PKC serve as mediators between endothelial cell membrane depolarization and NOX2 assembly. mechanotransduction; endothelium; NADPH oxidase; membrane potential; phosphorylation; phosphoinositide 3-kinase; reactive oxygen species; protein kinase C THE PLASMA MEMBRANE of endothelial cells (ECs) in situ is continuously subjected to a variable shear stress that is associated with luminal blood flow. Our studies (2, 4, 5, 27, 32, 35, 39, 45) have focused on the signaling response to the abrupt decrease of shear that occurs with the stop of flow (i.e., ischemia). Studies of intact perfused rat and mouse lungs and flow-adapted ECs in primary culture have shown that the cessation of flow results in an immediate response that is characterized by the generation of ROS associated with the activation of EC NADPH oxidase (NOX) (4, 35, 45) . These experiments on ischemia were done under conditions that maintained normoxia so that ROS generation in this model was not the result of a changed metabolic state but rather reflected the effect of altered mechanotransduction.
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The NOX enzyme family has been categorized into seven members (NOX1-NOX5 and DUOX-1 and DUOX-2) depending on the membrane-associated flavoprotein components (7, 20, 38) . The prototype (NOX2) is composed of two integral membrane proteins: p22 phox and glycoprotein (gp)91 phox , which together constitute cytochrome b558, and four cytosolic proteins (Rac1 or Rac2, p40
phox , p47 phox , and p67 phox ) (20, 23) . Upon activation, NOX2-related cytosolic proteins translocate to the plasma membrane and associate with integral membrane subunits to form the functional enzyme (23, 26) . Our studies (4, 31, 44) using gp91 phox -null mice have indicated that NOX2 is the NOX that generates ROS in the endothelium during ischemia.
Based on our studies of ischemia (5, 6, 13, 35, 45) , the signaling cascade that results in ROS production is initiated by EC membrane depolarization associated with the inactivation of ATP-sensitive K ϩ (K ATP ) channels. We have postulated that this K ATP channel response reflects the loss of fluid shear stress as sensed by caveolae and that the membrane depolarization, in turn, triggers the assembly and activation of NOX2 (13, 30, 45) . However, the intermediate steps that link depolarization and NOX2 activation are not clear. Previous studies (1, 8, 22, 36, 41) have implicated phosphoinositide 3-kinase (PI3K) in the activation of NOX2 in various cell systems. We (44) have previously shown in the isolated mouse lung that wortmannin, a PI3K inhibitor, prevents the translocation of NOX2 subunits and reduces ROS production with ischemia. The present study further evaluated the role of PI3K and its downstream effector, the serine threonine kinase Akt (also called PKB), as well as PKC, in the signaling events that lead to ischemia-mediated activation of ROS generation by mouse pulmonary microvascular ECs (PMVECs).
MATERIALS AND METHODS
Materials. Bis-(1,3-dibutylbarbituric acid)trimethine oxonol (bisoxonol), dichlorodihydrofluoroscein diacetate (H2DCF-DA), diphenyleneiodonium chloride (DPI) and Alexa fluor 594-conjugated wheat germ agglutinin were purchased from Invitrogen (Eugene, OR). Cromakalim (a K ATP channel agonist) and wortmannin were from Sigma (St. Louis, MO). H7 dihydrochloride was from Calbiochem (San Diego, CA). The PI3K activity assay kit was from Echelon Biosciences (Salt Lake City, UT). The antibodies used were anti-Rac1, anti-von Willebrand factor (vWF), and anti-p85 from Upstate Biotechnology (Lake Placid, NY), anti-phosphorylated (p)Ser 273 Akt from Cell Signaling (Beverly, MA), Akt from Santa Cruz Biotechnology (Santa Cruz, CA) and Millipore (Billerica, MA), anti-platelet-EC adhesion molecule (PECAM-1) sheep polyclonal from Centa-cor (Malvern, PA), anti-PECAM monoclonal from BD Biosciences (San Jose, CA), FITC-labeled anti-CD31 (PECAM-1) from Millipore (Billerica, MA), anti-vascular endothelial (VE)-cadherin from Transduction Labs (San Diego, CA), anti-Flk-1 and anti-Flk-2 from Chemicon (Temecula, CA), and fluorophore-labeled goat anti-mouse or anti-rabbit IgG from Invitrogen.
Animals. Animal use was reviewed and approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania. Male C57BL/6 mice weighing ϳ20 g were obtained from Jackson Labs (Bar Harbor, ME). Breeding pairs of mice deficient in K ATP channels generated by targeted disruption of the gene for Kir6.2 were obtained from Chiba University (29) and bred in the University of Pennsylvania animal facilities as previously described (45) . K ir6.2 is the pore-forming subunit of the K ATP channel in lung ECs (10, 13) .
Ϫ/Ϫ mice have been backcrossed for five generations to the C57BL/6 background. Except for differences in coat color related to the chromosomal location of the K ir6.2 locus, there were no obvious phenotypic differences between the wild-type and gene-targeted mice. NOX2-null mice (made by gene targeting for gp91 phox ) were obtained from Jackson Labs. These mice have been used as a model of chronic granulomatous disease (17) . Akt1-and Akt2-null mice were generated in our facilities and have been previously described (15); they have been backcrossed for 10 generations to the C57BL/6 background.
Isolation of mouse PMVECs. Mouse PMVECs were isolated by collagenase treatment of minced mouse lungs and cell adhesion to Dynabeads (Dynal, Oslo, Norway) coated with polyclonal anti-rat PECAM as previously described (13, 30) . Isolated cells were maintained for several passages under static culture conditions in DMEM supplemented with 10% FBS, EC growth supplement, nonessential amino acids, and penicillin-streptomycin. The endothelial phenotype of the preparation was confirmed by cellular uptake of the EC-specific marker DiI-acetylated LDL (DiIAcLDL) and by immunostaining for EC marker proteins: PECAM-1, vWF, VE-cadherin, Flt-1 (VEGF receptor-1), and Flk-1 (VEGF receptor-2). Confluent mouse PMVECs were incubated with DiIAcLDL at a final concentration of 10 g/ml for 1 h at 37°C, washed three times with fresh medium, and evaluated by epifluorescence microscopy at excitation/emission wavelengths of 545/585 nm. For immunostaining, cultured cells were split and incubated with either a primary antibody or with nonimmune IgG for 3 h at 37°C, washed, incubated with a secondary antibody (goat antimouse or anti-rabbit IgG conjugated with Alexa fluor 488 or FITC at 1:100 dilution), and then examined under a Nikon Optiphot microscope.
Isolated lung perfusion and intravital microscopy. The isolated perfused lung technique used in this study for mouse lungs has been previously described (13, 44, 45) . Briefly, mice were anesthetized with 50 mg/kg ip pentobarbital sodium and continuously ventilated through a tracheal cannula with 5% CO2 in air (BOC Group, Murray Hill, NJ). The chest was opened, and the pulmonary circulation was cleared of blood by gravity flow of perfusion through a cannula inserted in the main pulmonary artery, exiting from the transected left ventricle. The perfusate was Krebs-Ringer bicarbonate solution [composed of (in mM) 118.45 NaCl, 4.74 KCl, 1.17 MgSO4·7H2O, 1.18 KH2PO4, and 24.87 NaHCO3] supplemented 10 mM glucose and 5% dextran to maintain osmolarity. The lungs were dissected free and placed in a chamber with ports connected to a ventilator and to a peristaltic pump that maintained the lung perfusion rate at 2 ml/min (44) .
Intravital imaging was carried out as previously described (4, 13, 35, 37, 44, 45) . The lung preparation was placed onto a chamber on the stage of an epifluorescence microscope equipped with an optical filter changer (lambda 10-2, Sutter Instruments, Novato, CA), a Hamamatsu ORCA-100 digital camera (Hamamatsu, Bridgewater, NJ), and MetaMorph imaging software (Universal Imaging, Downingtown, PA). Excitation of the lung surface was accomplished with a mercury lamp fiber optic light source. The change in bis-oxonol fluorescence (480 Ϯ 20-nm excitation/535 Ϯ 25-nm emission) was used to determine changes in EC membrane potential, and 2=,7=-dichlorofluorescin (DCF) fluorescence (485 Ϯ 5-nm excitation/510 Ϯ 10-nm emission) was used for ROS production. Isolated lungs were preperfused with bis-oxonol (0.2 M) or H2DCF-DA (5 M) for 30 min to allow for uptake of the fluorophore. Bis-oxonol intercalates into the cell membrane, while intracellular cleavage of the diacetate from H 2DCF-DA results in cell trapping of H2DCF. The remaining intravascular dye was removed by 10 min of perfusion of the lungs with dye-free buffer. In some experiments, wortmannin (100 nM) or H7 dihydrochloride (100 M) or a combination of the two was added to the dye loading solution in the preperfusion period. Wortmannin was used to inhibit PI3K, and H7 dihydrochloride was used as an inhibitor of PKC. The combination of the two was used to ascertain if there was any contribution of PI3K-and PKC-independent pathways in the generation of ROS with pulmonary ischemia. For each lung perfusion experiment, images from six randomly selected fields were averaged to obtain a mean value for fluorescence.
Flow adaptation of PMVECs. ECs were plated on a Pronectintreated optically clear plastic slide, which was placed in a temperature-controlled (37°C) confocal imaging chamber (Warner Instruments, Hamden, CT). Flow adaption of cells was accomplished in the chamber by the flow of medium at 10 dyn/cm 2 for 24 h through in-flow and out-flow perfusion ports. For live cell imaging of flowadapted ECs, the chamber was mounted on a microscope stage, allowing the monitoring of cell fluorescence with changes of flow. The PO2 level in the confocal chamber remained satisfactory for as long as 1 h after the stop of flow, as monitored using a phosphorescence probe (PdP1) that showed increasing phosphorescence with decreased perfusate PO2 (11, 28) .
ECs also were flow adapted in an artificial capillary system (Cellmax Quad, Cellco, Germantown, MD) to obtain a relatively large number of cells for performing biochemical assays. This method allows ischemia without cellular anoxia or nutrient deprivation and has been previously described (31, 32, 39) .
PI3K activity assay. Cellular PI3K activity was measured using a kit supplied by Echelon Biosciences, as previously described (44) . The assay uses a competitive ELISA to measure the amount of phosphatidylinositol (3,4,5)-triphosphate [PI(3,4,5)P3] produced from phosphatidylinositol (4,5)-bisphosphate (PIP2). ECs were lysed, and anti-PI3K antibody was added followed by a 50% slurry of protein A agarose beads to immunoprecipitate PI3K, which was used for the assay. PI(3,4,5)P3 standards and controls supplied in the kit were used to generate a standard curve.
Infection of PMVECs with Adp85 dominant negative PI3K. Cells were infected with an adenoviral vector containing cDNA encoding dominant negative PI3K (mutant p85 subunit), which was obtained from Harold Franch (Emory School of Medicine, Atlanta, GA) (21). The amplified virus was titered and used for expression experiments. For adenoviral infections, 2 ϫ 10 5 PMVECs were plated in a 60-mm culture dish, and cells were rinsed with serum-free medium and then infected (100 particles/cell) with adenovirus encoding dominant negative PI3K or empty vector.
Rac1 localization after ischemia. Localization of Rac1 GTPase in mouse PMVECs after infection with adenovirus encoding dominant negative PI3K was evaluated under conditions of cell membrane depolarization induced either by ischemia or by high K ϩ and compared with control cells (noninfected or infected with vector only). Cells were flow adapted (10 dyn/cm 2 ) for 24 h and subjected to stop of flow or continuously perfused with 24 mM K ϩ for 30 min. Cells were then fixed with ice-cold methanol-acetone (1:1) and immunostained using a monoclonal Rac1 antibody (1:200). The EC membrane was visualized using Alexa fluor 594-conjugated wheat germ agglutinin (4 g/ml). A yellow colabel in the merged image indicates the colocalization of Rac with the EC membrane. The fluorescence intensity of Rac1 on the EC membrane was quantitated by Metamorph software, which marked the colabeled region, and was normalized to the length of the cell perimeter.
RESULTS

EC membrane depolarization with ischemia in wild-type and Akt-null lungs and the effects of inhibitors.
The membrane polarity-sensitive dye bis-oxonol was used for the imaging of subpleural microvessels in mouse lungs to detect changes in membrane polarization with ischemia. No change in fluorescence was found during continuous perfusion. However, an increase in fluorescence was observed within 30 -60 s after the cessation of flow, and the fluorescence signal remained relatively constant during the subsequent 4 min of observation (Fig. 1) . This result indicates a stable level of membrane depolarization subsequent to flow cessation. The K ATP channel agonist cromakalim blocked depolarization with ischemia in wild-type lungs (Fig. 1) , as previously shown (45) . This agonist prevents the K ATP channel inactivation that normally accompanies ischemia.
We next investigated whether PI3K/Akt activity has a role in EC membrane depolarization with ischemia. Pretreatment of isolated lungs with the PI3K inhibitor wortmannin had no effect on the observed changes in bis-oxonol fluorescence (Fig.  1) . Likewise, the change in fluorescence with ischemia in Akt1-null lungs was similar to wild-type lungs (Fig. 1) . The depolarization response in Akt1-null lungs was abrogated by cromakalim but was unaffected by the presence of wortmannin, as in wild-type lungs (Fig. 1) . These results indicate that depolarization of the EC membrane occurs with ischemia and is independent of both PI3K and Akt activities.
Ischemia results in PI3K/Akt activation in vitro. The relationship of PI3K activation to EC membrane depolarization was further evaluated in vitro using flow-adapted PMVECs subjected to ischemia; this model has been shown previously to result in cell membrane depolarization that depends on K ATP channels (13, 30) . Cell lysates were treated with an anti-p85 antibody to immunoprecipitate PI3K, which was then assayed for activity. Ischemia in wild-type cells resulted in PI3K activation, but this response was not observed in cells that lacked the K ATP channel (Fig. 2) . K ATP channel-null ECs do not show significant depolarization with ischemia (13, 30, 45) . Hence, depolarization is required for ischemia-induced activation of PI3K in ECs.
We next evaluated the possible ischemia-mediated activation (phosphorylation) of Akt, the downstream partner of PI3K. To detect activation, cells were fixed, immunostained with anti-pSer 473 Akt followed by secondary anti-mouse IgG-Alexa fluor 488 and imaged by confocal microscopy. Flow-adapted wild-type cells showed phosphorylation of Akt with ischemia, whereas no Akt phosphorylation was observed in K ATP channel-null cells or wild-type cells pretreated with cromakalim (Fig. 3A) . The presence of cromakalim or deletion of the K ATP channel largely prevented cell membrane depolarization with ischemia (13, 30) . However, cells that depolarized with ischemia, but did not produce ROS, such as DPI-treated cells (DPI pretreatment prevents NADPH oxidase activation), showed Akt phosphorylation (Fig. 3A) , indicating that phosphorlation occurred in the absence of ROS but not in the absence of depolarization. Cells cultured under static conditions were used as a negative control. Similar results were obtained by immunoblotting static and ischemic cells from wild-type, K ATP channel-null, and NOX2 (gp91 phox )-null animals for pAkt (Fig.  3B) . Quantitation of the lanes revealed that the phosphorylation of Akt in ischemic cells of wild-type and NOX2-null animals (i.e., cells that depolarized with ischemia) was 2.8-and 4-fold higher than their static controls, respectively. This was not observed in cells that do not depolarize with ischemia (i.e., K ATP channel-null cells). In addition, when wild-type cells were depolarized (by high K ϩ ), phosphorylation of Akt was observed, which was reduced (by 51%) in cells pretreated with cromakalim. In all these experiments, the total Akt content in these cells remained unchanged. Thus, activation of Akt with ischemia, as for PI3K, represents a downstream response to membrane depolarization.
ROS generation with ischemia in isolated lungs. We next investigated the relationship between activation of PI3K/Akt and ROS production with ischemia. ROS generation in isolated lungs was monitored by the oxidation of the ROS-sensitive dye H 2 DCF to DCF. Wild-type lungs showed a rapid increase in DCF fluorescence with ischemia, indicating ROS production (Fig. 4) , as previously shown (44, 45) . ROS production with ischemia was significantly reduced in lungs with knockout of Akt1, whereas the response of Akt2-null lungs to ischemia was similar to wild-type lungs (Fig. 4, A and B) . Thus, Akt1 is required for the activation of endothelial ROS production with ischemia. Based on the Akt2-null results, the marked decrease of ROS generation in Akt1-null lungs results specifically from loss of the protein and is not a general effect of an Akt-null phenotype.
Since PKC has also been reported to mediate ROS generation in vascular ECs, we investigated if the PI3K/Akt pathway intersects with PKC. To do this, we pretreated lungs with the PKC inhibitor H7 dihydrochloride and monitored ROS production with ischemia. ROS production with pulmonary ischemia was significantly reduced with PKC inhibition (Fig. 4, C  and D) . This inhibition was comparable with that achieved with the inhibitor of PI3K. The combination of the two inhibitors had no greater effect than either alone, indicating that PI3K and PKC are in the same rather than parallel pathways for ROS production with ischemia.
Rac1 translocation and membrane depolarization. Rac1 is a cytoplasmic protein that translocates to the cell membrane during activation of the NOX2 enzyme complex. Rac1 is the responsible isoform in PMVECs, and its translocation is required for ROS production with ischemia (44). We (44) have previously reported that membrane depolarization in PMVECs initiates Rac1 translocation from the cytosol to the membrane, and this translocation can be blocked by wortmannin. To extend these results, we monitored Rac1 translocation in dominant negative PI3K-infected cells subjected to ischemia (Fig. 5A ). Rac1 translocation also was evaluated after treatment of cells with 24 mM KCl (high K ϩ ) as a membrane depolarizing agent (Fig.  5B) . Based on the yellow colocalization signal, wild-type cells and AdlacZ (adenovirus control)-infected cells showed Rac1 translocation with both ischemia (Fig. 5A ) and high K ϩ (Fig.  5B) . On the other hand, Rac1 translocation with these agonists was significantly suppressed by dominant negative PI3K infection of PMVECs. Thus, PI3K activity is required for Rac1 translocation and subsequent NOX2 activation in response to EC membrane depolarization.
ROS are not required for the activation of PI3K/Akt and ROS with ischemia.
The results of the perfused lung experiments (Fig. 4) indicated that PI3K/Akt and PKC are necessary for ROS production with ischemia but do not exclude the possibility that ROS, in turn, may contribute to PI3K/Akt activation, essentially a positive feedback mechanism. This possibility was investigated in isolated cells that were devoid of NOX2 (gp91 phox null) and do not produce ROS with ischemia. Flow-adapted NOX2-null PMVECs showed the activation of PI3K (Fig. 2) and Akt1 (Fig. 3) with ischemia that was similar to wild-type PMVECs. Thus, the failure to gener- ate ROS had no effect on the activation of PI3K/Akt. Because of previous reports obtained with other systems (14, 19, 25, 42) , we determined if exogenous H 2 O 2 can lead to Akt phosphorylation in mouse PMVECs. Wild-type PMVECs were exposed for 2-3 min to H 2 O 2 at concentrations from 0.25 to 100 M. Akt activation (phosphorylation) was observed, but only when H 2 O 2 was present at relatively high concentrations (Ͼ10 M; Fig. 6 ). These results are compatible with previous reports using exogenous H 2 O 2 (9, 34, 42) . Although exogenous H 2 O 2 may have an effect that differs from the local generation of H 2 O 2 , these results suggest that H 2 O 2 does not activate Akt at concentrations that might be encountered physiologically. Thus, PI3K, Akt, and PKC appear to be downstream of cell membrane depolarization and upstream of ROS generation.
DISCUSSION
Our laboratory has been engaged in studies to delineate the response of PMVECs to altered shear. In this connection, we have established isolated perfused lung and in vitro flowadapted cellular models that are useful to study the response to alterations of the mechanical component of flow without the attendant tissue hypoxia or anoxia that accompanies the stop of blood flow in vascular beds of other organs (2, 4 -6, 10, 13, 31, 35, 37, 44, 45) . Removal of fluid shear stress from flowadapted cells represents a relevant in vitro model in the sense that the normal endothelium in situ is constantly exposed to flow (shear) and the cessation of blood flow occurs with various pathologies, such as pulmonary embolism or lung transplantation. In contrast, the response to initiation of shear with cells grown under static conditions is a less physiological model even though the resulting response may follow pathways similar to those accompanying flow cessation (16) . The signaling events that accompany the changes in fluid shear stress to ECs are considered to be an example of mechanotransduction.
Our studies have relied heavily on the use of fluorophores, especially DCF in the present study, to detect ROS generation in the intact lung. DCF oxidation is often considered an inadequate readout for ROS generation; however, our earlier imaging studies showed a correspondence of the DCF signal with ROS generation as evaluated by several methods in our models of ischemia in lungs and flow-adapted ECs. First, the (30, 44, 45) . Second, increased fluorescence compatible with ROS was demonstrated with several other fluorophores (amplex red and dihydroethidine) (3, 35, 44, 45) . Third, an increase in ROS with stopped flow in flow-adapted ECs was demonstrated by SOD-dependent reduction of cytochrome c (27) . DCF, unlike hydroethidine, does not detect superoxide but does detect H 2 O 2 , the presumed dismutation product of superoxide generated by NOX2 activation with pulmonary ischemia. Hence, DCF oxidation in our model appears to be dependent on the presence of ROS (H 2 O 2 ).
We (4, 35, 44, 45) have previously reported using isolated lungs or flow-adapted cells in vitro that abrupt the cessation of flow causes a rapid (within 1 min) increase in ROS production by the pulmonary endothelium. Fluorescence imaging of membrane polarity in the intact lung showed that EC membrane depolarization preceded ROS generation and occurred within seconds of stopped flow (2, 5, 35, 44, 45) . Depolarization required the presence of intact caveolae (30) . By patch clamp of flow-adapted cells in vitro, stop of flow resulted in an immediate decrease of K ir current, indicating essentially immediate depolarization with an abrupt loss of shear. Cells with "knockout" of K ir 6.2 had almost no change in membrane potential and markedly reduced ROS production with ischemia (13, 45) . Thus, membrane depolarization is followed by ROS production, associated with a loss of fluid shear stress, and this relationship has been observed both for the pulmonary endothelium in situ as well as flow-adapted PMVECs in vitro. The absence of ROS generation with ischemia in lungs and flowadapted pulmonary ECs from NOX2 gene-targeted mice indicate that this NOX isoform is the source of ROS (5, 31). The relation- ship between EC membrane potential and NOX2 activation was confirmed by exposing cells to high extracellular K ϩ to depolarize the EC membrane (30, 44) . Although previous studies established that cell membrane depolarization signals for NOX activation, the pathway connecting these events was not clear.
We (44) have previously shown that EC membrane depolarization induced by high K ϩ results in PI3K activation. The present study investigated PI3K, Akt, and PKC activation as links between EC membrane depolarization and NOX activation using inhibitors of PI3K (wortmannin) and PKC (H7), infection with dominant negative PI3K, and Akt gene targeting. We (44) have previously reported that treatment of mouse lungs or isolated mouse flow-adapted PMVECs with the PI3K/ Akt inhibitor wortmannin reduces ROS production with ischemia. In the present study, the results using a dominant negative construct showed that the translocation of Rac1 with depolarization (the initial step in NOX2 activation) requires PI3K. We also showed that inhibition of PKC (by H7) markedly diminished ROS generation with ischemia, with a magnitude comparable with that of PI3K inhibition by wortmannin. The combination of wortmannin and H7 had no greater effect than either alone. These results indicate that PI3K/Akt and PKC are in the same pathway and are required for ROS generation with ischemia. PKC has been reported to be involved in NOX2 activation in vascular ECs via the phosphorylation of p47 phox (43) . Another possible target of PKC is the phosphorylation of peroxiredoxin 6 (40), a recently described component of the NOX2 activation cascade (12) .
Although wortmannin prevented NOX2 activation, it had no effect on cell membrane depolarization. PI3K activity was significantly enhanced in cells that showed depolarization with ischemia (wild-type and NOX2-null cells) but was unaffected with ischemia in the absence of depolarization (K ATP channelnull cells). Thus, membrane depolarization results in PI3K activation. But how are membrane potential and PI3K activity linked? A previous study (46) has indicated that an imposed electrical field can modulate PI3K activity in HL60 cells. This latter study also showed that exposure to an electrical field modified the potential difference across membranes and led to PI3K, Src, and Akt activation. However, in cells where the p110 subunit of PI3K was deleted, the activation of Akt and Src under a similar electrical stimulus was significantly impaired. PI3K may have one or more domains that are sensitive to alterations in membrane polarity. Another possibility for the membrane potential effect relates to substrate availability. Membrane depolarization has been shown to activate phosphatase activity in both Xenopus oocytes and Chinese hamster ovary cells transfected with a voltage sensor containing phosphatase from Ciona intestinalis, resulting in perturbation of the PIP2 pool (18, 24, 33) . Thus, it is possible that membrane depolarization associated with ischemia activates PI3K directly through a membrane potential-sensitive domain or indirectly through the activation of phosphoinositide phosphatases that modulate PIP2 concentrations.
Depolarization of the lung endothelium with ischemia was also unaffected by deletion of Akt1. Furthermore, pretreatment of Akt1-null lungs with the K ATP channel agonist cromakalim prevented the depolarization response with ischemia, similar to the wild-type response. Thus, EC membrane depolarization with ischemia is independent of Akt. On the other hand, ROS generation after ischemia in Akt1-null lungs was significantly reduced compared with either wild-type lungs or Akt2-null lungs. Thus, Akt1 activation with ischemia, like PI3K activation, is downstream of cell membrane depolarization but upstream of NOX2 activation. To summarize, our data indicate that flow cessation results in cell membrane depolarization, which is followed by PI3K/ Akt and PKC activation, which, in turn, causes NOX assembly and ROS generation. We speculate that the activity of PI3K is regulated either by a voltage-sensitive domain in the protein or by phosphatase-mediated changes in substrate concentration and that this change in activity depends on changes in the EC membrane potential.
